196 related articles for article (PubMed ID: 8380454)
1. NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region.
Kyo S; Inoue M; Nishio Y; Nakanishi K; Akira S; Inoue H; Yutsudo M; Tanizawa O; Hakura A
J Virol; 1993 Feb; 67(2):1058-66. PubMed ID: 8380454
[TBL] [Abstract][Full Text] [Related]
2. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.
Baldwin A; Pirisi L; Creek KE
J Virol; 2004 Apr; 78(8):3953-64. PubMed ID: 15047811
[TBL] [Abstract][Full Text] [Related]
3. Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines.
Kyo S; Inoue M; Hayasaka N; Inoue T; Yutsudo M; Tanizawa O; Hakura A
Virology; 1994 Apr; 200(1):130-9. PubMed ID: 8128617
[TBL] [Abstract][Full Text] [Related]
4. NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A.
Spergel JM; Hsu W; Akira S; Thimmappaya B; Kishimoto T; Chen-Kiang S
J Virol; 1992 Feb; 66(2):1021-30. PubMed ID: 1309887
[TBL] [Abstract][Full Text] [Related]
5. Identification of a transcriptional regulatory factor for human aromatase cytochrome P450 gene expression as nuclear factor interleukin-6 (NF-IL6), a member of the CCAAT/enhancer-binding protein family.
Toda K; Akira S; Kishimoto T; Sasaki H; Hashimoto K; Yamamoto Y; Sagara Y; Shizuta Y
Eur J Biochem; 1995 Jul; 231(2):292-9. PubMed ID: 7635140
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.
Kyo S; Tam A; Laimins LA
Virology; 1995 Aug; 211(1):184-97. PubMed ID: 7645210
[TBL] [Abstract][Full Text] [Related]
7. Activity of human papillomavirus type 16 P97 promoter in immortal and tumorigenic human oral keratinocytes.
Kook JK; Kim JH; Min BM
Int J Oncol; 1998 Oct; 13(4):765-71. PubMed ID: 9735407
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus early region 3 promoter regulation by E1A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1.
Kornuc M; Kliewer S; Garcia J; Harrich D; Li C; Gaynor R
J Virol; 1990 May; 64(5):2004-13. PubMed ID: 2139139
[TBL] [Abstract][Full Text] [Related]
9. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
10. A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer.
O'Connor MJ; Stünkel W; Zimmermann H; Koh CH; Bernard HU
J Virol; 1998 Dec; 72(12):10083-92. PubMed ID: 9811748
[TBL] [Abstract][Full Text] [Related]
11. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
12. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.
Matsusaka T; Fujikawa K; Nishio Y; Mukaida N; Matsushima K; Kishimoto T; Akira S
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10193-7. PubMed ID: 8234276
[TBL] [Abstract][Full Text] [Related]
13. A functional NF-kappaB binding site in the human papillomavirus type 16 long control region.
Fontaine V; van der Meijden E; de Graaf J; ter Schegget J; Struyk L
Virology; 2000 Jun; 272(1):40-9. PubMed ID: 10873747
[TBL] [Abstract][Full Text] [Related]
14. A distal element in the HPV-11 upstream regulatory region contributes to promoter repression in basal keratinocytes in squamous epithelium.
Zhao W; Chow LT; Broker TR
Virology; 1999 Jan; 253(2):219-29. PubMed ID: 9918880
[TBL] [Abstract][Full Text] [Related]
15. Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA.
Stünkel W; Huang Z; Tan SH; O'Connor MJ; Bernard HU
J Virol; 2000 Mar; 74(6):2489-501. PubMed ID: 10684263
[TBL] [Abstract][Full Text] [Related]
16. NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter.
Combates NJ; Rzepka RW; Chen YN; Cohen D
J Biol Chem; 1994 Nov; 269(47):29715-9. PubMed ID: 7961962
[TBL] [Abstract][Full Text] [Related]
17. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.
May M; Dong XP; Beyer-Finkler E; Stubenrauch F; Fuchs PG; Pfister H
EMBO J; 1994 Mar; 13(6):1460-6. PubMed ID: 8137827
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
19. IL-6 and NF-IL6 in acute-phase response and viral infection.
Akira S; Kishimoto T
Immunol Rev; 1992 Jun; 127():25-50. PubMed ID: 1380488
[TBL] [Abstract][Full Text] [Related]
20. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6.
Natsuka S; Akira S; Nishio Y; Hashimoto S; Sugita T; Isshiki H; Kishimoto T
Blood; 1992 Jan; 79(2):460-6. PubMed ID: 1730090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
